...W15,000 in an IPO underwritten by NH Investment & Securities. FutureChem Co. Ltd. (KOSDAQ:220100), Seoul, South Korea
Alicia Parker
FutureChem Co. Ltd....
...Bayer's Bayer Schering Pharma AG division received exclusive, worldwide rights to FutureChem's fluorine-18 (F-18) radiolabeling technology... ...disease and for treatment monitoring. Financial terms were not disclosed. Bayer AG (FSE:BAY), Leverkusen, Germany FutureChem Co. Ltd....
...W15,000 in an IPO underwritten by NH Investment & Securities. FutureChem Co. Ltd. (KOSDAQ:220100), Seoul, South Korea
Alicia Parker
FutureChem Co. Ltd....
...Bayer's Bayer Schering Pharma AG division received exclusive, worldwide rights to FutureChem's fluorine-18 (F-18) radiolabeling technology... ...disease and for treatment monitoring. Financial terms were not disclosed. Bayer AG (FSE:BAY), Leverkusen, Germany FutureChem Co. Ltd....